Existing drug tested as potential brain injury treatment
NCT ID NCT06790095
Summary
This study is testing whether an existing, FDA-approved drug can help people recover better from a severe traumatic brain injury (TBI). The drug is being used 'off-label,' meaning it's not yet approved for TBI. Researchers will compare recovery in a small group of 26 adults who receive the drug versus a placebo, measuring disability, brain scans, and blood markers over six months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRAUMATIC BRAIN INJURY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of California, San Francisco
San Francisco, California, 94110, United States
Conditions
Explore the condition pages connected to this study.